Quick Takeaways
- PERCEPTIVE ADVISORS LLC filed SCHEDULE 13G for Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX).
- Disclosed ownership: 5.5%.
- Date of event: 13 Feb 2025.
PERCEPTIVE ADVISORS LLC - 13 Feb 2025 SCHEDULE 13G Report for Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX)
- Filing Manager
- PERCEPTIVE ADVISORS LLC
- Reporting Manager
- Perceptive Advisors LLC
- Symbol
- EWTX
- Shares outstanding
- 93,899,764 shares
- Disclosed Ownership
- 5,164,487 shares
- Ownership
- 5.5%
- Form type
- SCHEDULE 13G
- Filing time
- 21 Feb 2025, 17:57:14 UTC
- Date of event
- 13 Feb 2025
- Next filing
- 15 May 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"PERCEPTIVE ADVISORS LLC disclosed 5.5% ownership in Edgewise Therapeutics, Inc. Common Stock, par value $0.0001 per share (EWTX) on 13 Feb 2025."
What Changed
- No earlier schedule filing is available for direct comparison.
- Current filing was accepted on 21 Feb 2025, 17:57.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (3)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Perceptive Advisors LLC | 5.5% | 5,164,487 | 0 | 5,164,487 | /s/ Joseph Edelman | Joseph Edelman, Managing Member | |
| Joseph Edelman | 5.5% | 5,164,487 | 0 | 5,164,487 | /s/ Joseph Edelman | Joseph Edelman | |
| Perceptive Life Sciences Master Fund, Ltd. | 5.5% | 5,164,487 | 0 | 5,164,487 | /s/ Joseph Edelman | Joseph Edelman, Managing Member |